P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 209 500 KRW -4.34% Market Closed
Market Cap: 2.2T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

PharmaResearch Co Ltd
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PharmaResearch Co Ltd
Net Income Peer Comparison

Comparables:
068270
302440
H
145020
N
007390
196170

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Net Income
â‚©90.8B
CAGR 3-Years
28%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Net Income
â‚©320.9B
CAGR 3-Years
-19%
CAGR 5-Years
7%
CAGR 10-Years
10%
SK Bioscience Co Ltd
KRX:302440
Net Income
â‚©22.3B
CAGR 3-Years
-12%
CAGR 5-Years
20%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Net Income
â‚©119B
CAGR 3-Years
27%
CAGR 5-Years
13%
CAGR 10-Years
N/A
N
NatureCell Co Ltd
KOSDAQ:007390
Net Income
-â‚©5.7B
CAGR 3-Years
51%
CAGR 5-Years
N/A
CAGR 10-Years
-44%
Alteogen Inc
KOSDAQ:196170
Net Income
-â‚©3.6B
CAGR 3-Years
34%
CAGR 5-Years
17%
CAGR 10-Years
N/A

See Also

What is PharmaResearch Co Ltd's Net Income?
Net Income
90.8B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Net Income amounts to 90.8B KRW.

What is PharmaResearch Co Ltd's Net Income growth rate?
Net Income CAGR 5Y
47%

Over the last year, the Net Income growth was 58%. The average annual Net Income growth rates for PharmaResearch Co Ltd have been 28% over the past three years , 47% over the past five years .

Back to Top